Medicus Pharma (MDCX) Return on Assets (2025)

Medicus Pharma (MDCX) posted Return on Assets of 0.02% for Q4 2025, down 40.62% quarter-over-quarter from 0.01% in Q3 2025.

Medicus Pharma (MDCX) Return on Assets (2025) Analysis & Trends

Medicus Pharma (MDCX) has reported Return on Assets for 1 consecutive years, with 0.02% the latest figure, recorded in Q4 2025.

Return on Assets for Q4 2025 came in at 0.02%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.02% (changed N/A YoY), and the FY2025 annual result was 0.04%, down 1.0% from the prior year.
Return on Assets was 0.02% for Q4 2025 at Medicus Pharma, down from 0.01% in the prior quarter.
Over five years, Return on Assets peaked at 0.01% in Q3 2025 and troughed at 0.03% in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	0.00%
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	0.00%
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	0.00%
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	0.00%
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	0.00%
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	0.00%
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	0.00%
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	0.00%
9	Novartis Ag	113.45 Bn	113.67 Bn	-	-
10	Medicus Pharma	6.91 Mn	-1.69 Mn	-	-0.02%

Download Data